Bibliographic information
GuidelineWHO guidelines for the clinical management of filovirus disease
Year of Publication2026
Issuing InstitutionWorld Health Organization
Recommendation
New
WHO suggests for the use of tranexamic acid in patients with confirmed filovirus disease and postpartum haemorrhage.
Recommended in favor
Conditional
Certainty of evidence
Low
Notes and Remarks
- Employ standard care protocols for postpartum haemorrhage, including a uterotonic (oxytocin is preferred where available). • Tranexamic acid should be given intravenously within 3 hours of birth.